26 Results for "

cannabinoid receptor 2

" in MedChemExpress (MCE) Product Catalog:
Products (26)

26 Results for "cannabinoid receptor 2" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-15451
CAS No.: 1048973-47-2
Purity:  99.26%
Synonyms: BZO-HEXOXIZID
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14900
CAS No.: 916591-01-0
Purity:  99.94%
Synonyms: GRC-10693
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment .
loading...
    loading...
Cat. No.: HY-14167
CAS No.: 666260-75-9
Purity:  99.97%
GW842166X is a potent and selective cannabinoid receptor 2 (CB2) agonist with IC50 values of 63 and 91 nM for human and rat CB2, respectively.
loading...
    loading...
Cat. No.: HY-110036
CAS No.: 180002-83-9
Purity:  99.12%
Synonyms: L768242
GW-405833 (L768242) is a potent, selective cannabinoid receptor 2 (CB2) agonist. GW405833 has EC50 and Ki values ​​of 0.65 nM and 3.92 nM for CB2, and EC50 and Ki values ​​of 16.1 μM and 4772 nM for CB1. GW-405833 also exhibits non-competitive CB1 antagonist, exerting its analgesic and and anti-inflammatory effect through a CB1 receptor (rather than CB2) dependent mechanism. GW-405833 can significantly inhibit the production of cAMP stimulated by Forskolin (HY-15371). GW405833 inhibits glycolysis by down-regulating HIF-1α, thereby alleviating acute liver failure (ALF) .
loading...
    loading...
Cat. No.: HY-N0688
CAS No.: 13476-25-0
Linderane is an orally active natural sesquiterpene lactone with blood-brain barrier permeability. Linderane indirectly activates PDE3 by activating ERK/STAT3, thereby inhibiting the cAMP/PKA/CREB signaling pathway and hepatic gluconeogenesis. Linderane protects pancreatic β cells against oxidative damage by inhibiting the activation of the p38 MAPK pathway and activating the Nrf2 pathway. Linderane inhibits cell apoptosis and ameliorates intestinal mucosal inflammation by suppressing the IL-6/JAK/STAT3 signaling pathway. Linderane reduces pain sensitivity and alleviates anxiety-like behaviors by activating cannabinoid receptor 2 (CB2R). Linderane can be used in studies related to type 2 diabetes, ulcerative colitis, and chronic inflammatory pain with anxiety .
loading...
    loading...
Cat. No.: HY-110050
CAS No.: 511532-96-0
Purity:  99.66%
GP1a is a potent agonist of cannabinoid receptor 2 (CB2). Gp1a is beneficial to skin wound healing. GP1a inhibits inflammation and fibrogenesis while promoting re-epithelialization .
loading...
    loading...
Cat. No.: HY-110036A
CAS No.: 1202865-22-2
Purity:  99.59%
Synonyms: L768242 hydrochloride
GW405833 (L768242) hydrochloride is a potent, selective cannabinoid receptor 2 (CB2) agonist. GW405833 has EC50 and Ki values ​​of 0.65 nM and 3.92 nM for CB2, and EC50 and Ki values ​​of 16.1 μM and 4772 nM for CB1. GW405833 hydrochloride also exhibits non-competitive CB1 antagonist, exerting its analgesic effect through a CB1 receptor (rather than CB2) dependent mechanism. GW405833 hydrochloride can significantly inhibit the production of cAMP stimulated by Forskolin (HY-15371). GW405833 hydrochloride inhibits glycolysis by down-regulating HIF-1α, thereby alleviating acute liver failure (ALF) .
loading...
    loading...
Cat. No.: HY-100778
CAS No.: 1054451-07-8
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

SMM-189 is  a potent and selective cannabinoid receptor 2 (CB2) inverse agonist. SMM-189 plays an important role in neurodegenerative disorders and traumatic brain injury research .
loading...
    loading...
Cat. No.: HY-173083
CAS No.: 1103840-28-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

MDA7 is the selective agonist for cannabinoid receptor 2 with EC50 of 128 nM and 67.4 nM in human CB2 receptor and rat CB2 receptor. MDA7 exhibits good affinity to human CB2 receptor and rat CB2 receptor with Ki of 422 nM and 238 nM. MDA7 exhibits analgesic activity in rats models .
loading...
    loading...
Cat. No.: HY-168734
CAS No.: 2374894-21-8
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

CB2 receptor agonist 9 (Compound 33) is an orally active agonist for cannabinoid receptor 2 (CB2 receptor) with an EC50 of 16.2 nM. CB2 receptor agonist 9 inhibits the expression of TNF-α, IL-1β and IL-6, exhibits anti-inflammatory efficacy in DDS (HY-116282)-induced mouse acute colitis model .
loading...
    loading...
Cat. No.: HY-175481
CAS No.: 182496-82-8
CB2R agonist 4 is a cannabinoid receptor 2 (CB2R) agonist with an EC50 value of 6.9 μM. CB2R agonist 4 can induce cell apoptosis, ROS production and protein misfolding. CB2R agonist 4 shows cytotoxicity to a panel of tumor cell lines. CB2R agonist 4 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-172568
(±)5(6)-EET Ethanolamide is a metabolite of Anandamide (HY-10863) generated via oxidation by cytochrome P450 enzymes. (±)5(6)-EET Ethanolamide is also a selective cannabinoid receptor 2 (CB2) agonist. (±)5(6)-EET Ethanolamide has Ki values of 11.4 μM and 8.9 nM for human CB1 and CB2, respectively . (±)5(6)-EET Ethanolamide can be used in research on immunomodulation and neuroinflammation .
loading...
    loading...
Cat. No.: HY-P1397
CAS No.: 1193362-76-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

RVD-Hpα, an α-hemoglobin-derived peptide containing three additional amino acids, is a CB1 cannabinoid receptor agonist. RVD-Hpα is a positive allosteric modulator of cannabinoid receptor 2 .
loading...
    loading...
Cat. No.: HY-P700636
Purity:  ≥ 95%, as determined by HPLC.
Synonyms: CNR2; CX5; cannabinoid receptor 2; HCB2; CB2; CB2B; cannabinoid receptor 2 (Macrophage); CB2A; CB-2
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P702255
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CNR2; CX5; cannabinoid receptor 2; HCB2; CB2; CB2B; cannabinoid receptor 2 (Macrophage); CB2A; CB-2
Species:  
Human
Source:  
E. coli Cell-free
loading...
    loading...
Cat. No.: HY-149644
CAS No.: 444331-43-5
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

CB2R agonist 3 is an agonist of cannabinoid receptor 2 (CB2R), with EC50 of 0.37μM that plays an important role in immune system .
loading...
    loading...
Cat. No.: HY-P702793
Purity:  Purity analysis by SDS-PAGE is not available for VLP proteins.
Synonyms: CNR2; CX5; cannabinoid receptor 2; HCB2; CB2; CB2B; cannabinoid receptor 2 (Macrophage); CB2A; CB-2
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-149993
CAS No.: 2923366-36-1
hBChE-IN-2 (compound 15d) is a butyrylcholinesterase (BChE) inhibitor (IC50 of 0.62 μM) and a cannabinoid receptor 2 (CB2R) agonist. hBChE-IN-2 has neuroprotection activities .
loading...
    loading...
Cat. No.: HY-15451R
CAS No.: 1048973-47-2
Synonyms: BZO-HEXOXIZID (Standard)
MDA 19 (Standard) is the analytical standard of MDA 19. This product is intended for research and analytical applications. MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity .
loading...
    loading...
Cat. No.: HY-168338
Research Areas:  

Cancer

CB2 receptor agonist 8 (Compound 17) is an agonist for cannabinoid receptor 2 (CB2 receptor). CB2 receptor agonist 8 exhibits cytotoxicity in cells U87, RPMI 8226, HL-60, and L929 with IC50s of 91.03, 16.29, 23.51 and 564.6 μM, respectively. CB2 receptor agonist 8 activates caspase 3/7, increases the expressions of pro-apoptotic genes BAX, BAD, BIM and tumor suppressor genes p53, and induces apoptosis in U87. CB2 receptor agonist 8 inhibits the migration of U87 .
loading...
    loading...